Histologic predictors of invasion in partially biopsied lentigo maligna melanoma
To the Editor: Because of its location and frequent large size, the initial diagnosis of LM (lentigo maligna) or LMM (lentigo maligna melanoma) is usually made by an initial partial biopsy rather than excisional biopsy, which, in LMM cases, could be performed in an area without an invasive component. In this study, we aimed to determine the frequency of patients with a final diagnosis of LMM undetected on the partial biopsy and find out pathologic predictors of invasion in LM biopsies.
We selected 118 consecutive cases from 115 patients with a biopsy-proven LM or LMM treated with Mohs or slow Mohs surgery during October 1999-May 2013. The partial biopsy slides of LM cases were compared by 2 dermatopathologists blinded to the final diagnosis (LM or LMM).
Of 100 cases with an initial diagnosis of LM after analysis of partial biopsy, 20% were upstaged to LMM after analysis of debulking specimens. LMM cases diagnosed after partial biopsy specimen analysis had a similar mean Breslow Index to those not diagnosed after partial biopsy (0.53 6 0.37 mm vs 0.47 6 0.34 mm, P ¼ .60). The sensitivity of the partial biopsy in detecting LMM was 47% (95% confidence interval 31%-64%) and the negative likelihood ratio 0.53 (95% confidence interval 0.39-0.71).
Clinical criteria (age, sex, size, type [ primary or recurrent]) were not significantly different between cases of LM and LMM initially diagnosed as LM. However, the multivariate logistic regression analysis revealed that a pagetoid spread of tumor cells and moderate-to-strong dermal inflammation on partial biopsy were significantly and independently associated with the final diagnosis of LMM (Table I) . Cases are grouped by the presence of the same top clone in both blood and skin and by frequency of the top clone in skin. Values are n/total (%) unless stated otherwise. Statistically significant differences are bolded. Statistical analysis was performed using the rank-sum test and Fisher's exact test (see Supplementary Appendix; available at http://www.jaad.org). Having the same top clone in blood and skin correlates with adverse risk features, whereas increased frequency of the top clone in the skin does not. CTCL, Cutaneous T-cell lymphoma; LDH, lactate dehydrogenase. *The clone frequency of those in the top 25th percentile was 5%; low frequency was considered \5%. In the literature, 3%-22% 1,2 of invasive melanomas were initially considered in situ on partial biopsy specimens. In our study, 90.7% (107/118) of partial biopsies were 3e4-mm punch biopsies, which reduced the surface area analyzed in comparison with the remaining 11 incisional biopsies and increased the risk of missing an invasive component. 3 Missing an invasion could lead to additional surgical procedures (ie, enlargement of the peripheral margin up to 1-2 cm according to Breslow thickness), resulting in the destruction of the prior wound closure and compromising the implementation of sentinel lymph node biopsy. Moreover, this might also lead to inadvertently treating occult invasive LMM nonsurgically. Alternative treatments to surgery, such as imiquimod (4.2%-50%), radiotherapy, or laser therapy, can represent interesting options for nonoperable patients. 4 But, these techniques are not indicated in cases of LMM and not recommended as first-line therapy for LM in guidelines.
Our study identified 2 independent pathologic predictors of dermal invasion on biopsy specimens of LM: pagetoid spread of tumor cells and presence of moderate-to-strong dermal inflammation. The presence of 1 of these criteria should lead to the performance of an additional hematoxylin-eosin stain or immunostain to search for an invasion 5 or additional biopsies. Of note, we did not take into account regression, which is conceptually defined as an indirect sign of a previous invasion and thus LMM. We propose an algorithm (Fig 1) to optimize LM and LMM management according to the presence of these 2 predictors of invasion. Noncultured epidermal suspension grafting using suction blisters as donor tissue for vitiligo To the Editor: Noncultured epidermal suspension (NCES) transplantation has been performed since 1992 to treat vitiligo, a chronic, autoimmune skin disorder characterized by depigmented macules and patches. 1 A new NCES technique was proposed, which involves forming suction blisters to obtain donor cells, because of the disadvantages of the standard grafting technique, such as the considerable amount of operator training required to harvest viable cells and potential scarring associated with using split-thickness grafts as donor tissue. 2 We performed a retrospective review of all patients undergoing NCES in the Pigmentary Disorders Clinic at the University of Texas Southwestern Medical Center. Patients were required to have at least 4e6 months of follow-up
